2 completed, 2 terminated, 1 active not recruiting, 1 not yet recruiting. 3 Phase 2, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Terminated 1 |
| Not applicable | 2 | Completed 1, Not yet recruiting 1 |
Follow Differentiated Thyroid Gland Carcinoma: new trials by email Literature Review of Differentiated Thyroid Gland Carcinoma trials Research Report on Differentiated Thyroid Gland Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial Internet-Based Intervention, Interview, Questionnaire Administration - Differentiated Thyroid Gland Carcinoma, Malignant Testicular Neoplasm | Not applicable | Not yet recruiting | University of Michigan Rogel Cancer Center | 142 | 2026-12-01 | 2026-10-15 |
| Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer Computed Tomography, Fluorine F 18 Tetrafluoroborate, Positron Emission Tomography - Differentiated Thyroid Gland Carcinoma, Thyroid Gland Follicular Carcinoma | Terminated | Mayo Clinic | 11 | 2022-04-22 | 2026-09-24 | |
| Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer Biospecimen Collection, Cabozantinib S-malate, Computed Tomography - Differentiated Thyroid Gland Carcinoma, Follicular Variant Thyroid Gland Papillary Carcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 11 | 2020-02-10 | 2026-07-31 |
| Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid Cancer Lenvatinib - Differentiated Thyroid Gland Carcinoma, Thyroid Gland Follicular Carcinoma | Phase 2 | Terminated | Emory University | 4 | 2019-01-16 | 2022-11-10 |
| Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer Computed Tomography, Dual X-ray Absorptiometry, Physical Examination - Differentiated Thyroid Gland Carcinoma, Malignant Adrenal Gland Pheochromocytoma | Not applicable | Completed | M.D. Anderson Cancer Center | 23 | 2015-11-16 | 2024-03-05 |
| Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery Laboratory Biomarker Analysis, Pharmacogenomic Study, Sunitinib - Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 63 | 2006-08-29 | 2025-03-28 |
Adenocarcinoma, Follicular (5) · Thyroid Cancer, Papillary (5) · Carcinoma, Medullary (2) · Thyroid Neoplasms (2) · Melanoma (1) · Paraganglioma, Extra-Adrenal (1) · Testicular Neoplasms (1)
Adenocarcinoma (6) · Carcinoma (6) · Neoplasms (6) · Neoplasms by Histologic Type (6) · Neoplasms, Glandular and Epithelial (6) · Adenocarcinoma, Papillary (5) · Endocrine Gland Neoplasms (5) · Endocrine System Diseases (5) · Head and Neck Neoplasms (5) · Neoplasms by Site (5) · Thyroid Diseases (5) · Neoplasms, Germ Cell and Embryonal (3) · Neoplasms, Nerve Tissue (3) · Neuroectodermal Tumors (3) · Neuroendocrine Tumors (3)
Magnetic Resonance Spectroscopy (2) · cabozantinib (2) · lenvatinib (2) · Absorptiometry, Photon (1) · CTLA-4 Antigen (1) · Interviews as Topic (1) · Ipilimumab (1) · Nivolumab (1) · Pharmacogenomic Testing (1) · Restraint, Physical (1) · Specimen Handling (1) · Sunitinib (1)
National Cancer Institute (NCI) (2) · Emory University (1) · M.D. Anderson Cancer Center (1) · Mayo Clinic (1) · University of Michigan Rogel Cancer Center (1)
United States (6)
Bhavana Konda (1) · Megan R Haymart, MD (1) · Naifa L Busaidy (1) · Stephen M. Broski, M.D. (1) · Tanguy Y Seiwert (1) · Taofeek K. Owonikoko, MD, PhD (1)
N01CM62201 (1), N01CM62202 (1), P30CA014599 (1), R34CA286602 (1), UM1CA186712 (1)